HIV-associated anorectal Epstein-Barr virus-positive mucocutaneous ulcer successfully treated with liposomal doxorubicin and rituximab

AIDS. 2019 Apr 1;33(5):929-930. doi: 10.1097/QAD.0000000000002143.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / immunology
  • AIDS-Related Opportunistic Infections / pathology*
  • Antibiotics, Antineoplastic / therapeutic use
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Epstein-Barr Virus Infections / drug therapy*
  • Epstein-Barr Virus Infections / immunology
  • Epstein-Barr Virus Infections / pathology
  • Humans
  • Male
  • Middle Aged
  • Polyethylene Glycols / therapeutic use
  • Rectal Diseases / drug therapy*
  • Rectal Diseases / pathology
  • Rectal Diseases / virology
  • Rituximab / therapeutic use*
  • Treatment Outcome
  • Ulcer / drug therapy*
  • Ulcer / pathology
  • Ulcer / virology

Substances

  • Antibiotics, Antineoplastic
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Rituximab
  • Doxorubicin